AzTrials
AzTrials

CommunicationNCT04212117

CALS Patient Activated Learning System (PALS)

A study testing The Patient Activated Learning System (PALS) and WebMD in people with Communication and Trust, run by Cornell University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall goal in this line of inquiry is to test whether the Patient Activated Learning System (PALS) is effective in reducing disparities in access to reliable, easily understood health information, and whether this increased understanding has downstream consequences such as increases in trust in the medical… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
The Patient Activated Learning System (PALS) and WebMD
Could I receive a placebo?
No, everyone receives an active treatment
How many people
232 participants
Where
1 siteUnited States
Study dates
18 Feb 2020to 1 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patient ≥ 18 years of age.
  • Self-reported hypertension diagnosis.
  • English speaking
  • Passing the cognition screener
  • Able to read in English
  • Patient at designated recruitment clinics

Who cannot join

  • Non-English speakers
  • Not having self-identified as having hypertension
  • Inability to read in English
  • Being younger than 18
  • Not passing the screener
  • Not being a patient on the participating clinics

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Weill Cornell Medicine

    New York, New York, 10021

Other trials in United States

About this study

Official title: Can the Digital Patient Activated Learning System Increase Racial Minority Engagement With Health Information? A Multi-Site Pilot Examination in New York State

The overall goal in this line of inquiry is to test whether the Patient Activated Learning System (PALS) is effective in reducing disparities in access to reliable, easily understood health information, and whether this increased understanding has downstream consequences such as increases in trust in the medical system and self-management behaviors.

Read the detailed description

Participants will view, in randomized order, PALS or WebMD content on hypertension and on high cholesterol. This study will test knowledge uptake across topics as well as attitudes toward and trust in the information and information providers.

Being tested
The Patient Activated Learning System (PALS), WebMD
Medical subject headings
Communication, Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Patient Activated Learning System (PALS)Other

    Randomization into PALS arm.

  • WebMDOther

    Randomization into WebMD arm.

Study groups in NCT04212117
Study groupRoleWhat they receive
Arm 1 - Educational Platform, PALSOtherThe Patient Activated Learning System is a free, health education platform written bu trusted MDs.
Receives: Other: The Patient Activated Learning System (PALS)
Arm 2 - WebMDOtherWebMD is a widely used educational platform for health information.
Receives: Other: WebMD

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knowledge

    as measured by assessment questions on the nutrition information provided

    Measured: Day 1, Immediately after reading article

  2. Trust in eHealth

    as measured by e-Health Impact Questionnaire by Kelly et al. on a 5-point likert scale where one is strongly disagree and 5 is strongly agree

    Measured: Day 1, Immediately after reading article

  3. E-health usability

    as measured by e-Health Impact Questionnaire scale by Harris et al. on a 5-point likert scale where one is strongly disagree and 5 is strongly agree

    Measured: Day 1, Immediately after reading article

  4. Physician trust

    as measured by assessment questions from Wake Forest Physician Trust Scale on a 5-point likert scale where one is strongly disagree and 5 is strongly agree

    Measured: Day 1, Immediately after reading article

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2019
  2. Study start18 Feb 2020
  3. Primary completion1 Nov 2023
  4. Study completion1 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
232 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04212117
Sponsor's protocol ID
19-08020714
Status last verified
Feb 2024
First submitted
23 Dec 2019
Last updated
13 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing The Patient Activated Learning System (PALS) and WebMD in people with Communication and Trust, run by Cornell University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knowledge (time frame: Day 1, Immediately after reading article). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in